Articles
| Open Access |
DOI: Meaning Of Respiratory Mycoplasma Infection In Children With Bronchial Asthma
Gulnoza Aloevna Toshmatova , Doctor Of Medical Sciences, Associate Professor, Department Of Children`S Diseases №1, Medical Faculty, Tashkent Medical Academy, Uzbekistan Maftuna Shukhrat Qizi Shakarova , Master Student Of 3rd Year, Department Of Children`S Diseases №2, Medical Faculty, Tashkent Medical Academy, Uzbekistan Arzi Ruslanovna Emirova , Master Student Of 3rd Year, Department Of Children`S Diseases №2, Medical Faculty, Tashkent Medical Academy, UzbekistanAbstract
Meaning and role of mycoplasma infection for children with bronchial asthma small studied. By us was inspected 39 children with BA in age from 2 to 14, from them 27 (69,2%) boys and 12 (30,8) girls. Obtained data from PChR testing is shown: among the children of patients with BA for 33,3% (13/39) patients found out M. pneumoniae.; for 66,7% (26/39) patients and for all children of control group M. pneumoniae. it is not discovered (table.№1). For children in a range 2-5, the more than half (53,8%) of children-asthmatics was got positive results of PChR; among the investigated children in age 6-14, only at 46,2% patients had M. pneumonia. Except it, among patients with BA, for 69,2% boys and 31% girls made the positive result of PChR, and correlation of sexes was made by 2,2: 1.
Keywords
Bronchial asthma, respiratory infection
References
Atkinson T.P., Balish M.F., Waites KB. Epidemiology, clinical manifestations,pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. - FEMS Microbiol. Rev.- 2008.-№32(6).-С.956–73.
Cengizlier M.R., Misirlioglu E.D. Evaluation of risk factors in patients diagnosedwith bronchial asthma. AllergolImmunopathol (Madr).-2006.-№34(1).-С.4–9.
Esposito S., Blasi F., Arosio C., Fioravanti L., Fagetti L., Droghetti R et al.Imporance of acute Mycoplasma pneumoniae and Chlamydia pneumonia infections in children with wheezing. EurRespir J.- 2000.-№16(6).С.1142–6.
Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert. Rev AntiInfect Ther.- 2008.-6(4).С.509–21.
MacDowell AL, Bacharier LB. Infectious triggers of asthma. Immunol AllergyClin North Am.- 2005.№25(1).-С.45–66.
Maclennan C, Hutchinson P, Holdsworth S, Bardin PG, Freezer NJ. Airwayinflammation in asymptomatic children with episodic wheeze. PediatrPulmonol.- 2006.-№41(6).-С.577–83.
Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasmapneumoniae infection with special reference to pneumonia. JInfectChemother.-2010.-№16(3).-С.162–9.
Agapova. O. Bronchial asthma: receptor interactions and not only ... On the search for new approaches in tactics and treatment and ongoing research. // Honey. gas. - 2017. - No. 74. - S. 12-13.
Bazhenov EE, Akhmedov VA, Ostapenko VA Clinical and pharmacological foundations of modern pulmonology: a textbook for the system of postgraduate professional education of doctors. / Moscow: BINOM. Knowledge laboratory, 2015.-55 p.
Belevsky AS Global strategy for the treatment and prevention of bronchial asthma (revision 2014) - Moscow: Russian Respiratory Society, 2015. - 148 p.
Geppe N.A. The urgency of the problem of bronchial asthma in children // Pediatrics. - 2012. - T. 91, No. 3. -S. 76-82.
Zakharova I.A., Belevsky A.S. Possibilities of treating virus-induced bronchial asthma // Bronchial asthma. - 2017. - No. 3. From 3-5.
Ilyenkova NA Concentrations of cytokines in bronchial asthma in patients depending on the degree of disease control // Doctor.RU. - 2018. - No. 4. - P. 44-47.
Kostinova M.P., Chuchalina A.G., Guide to clinical immunology in respiratory medicine / Moscow: ATMO, 2016. - 128 p.
Kostromina V.P., Strizh V.O., Matvianko Yu.O., Rechkina OO, Yaroshchuk L.B., Doroshenkova A.S. Clinical-and-nological criteria for differential diagnosis of bronchial asthma and bronchitis with broncho-obstructive syndrome in children // Asthma and allergy. - 2012. - No. 3. - S. 24-27.
Kupaev V.I. Cough variant of bronchial asthma // Asthma and Allergy. - 2018. - No. 3. From 13-15.
Kurbacheva OM, Pavlova KS Phenotypes and endotypes of bronchial asthma: from pathogenesis and clinical picture to the choice of therapy // Russian Allergological Journal. - 2013. - No. 1. - S. 15-24.
Lebedenko A. A. Analysis of the association of polymorphic variants of growth factors genes with the risk of developing bronchial asthma in children // Pulmonology. -2018- Vol.-28. No. 1. S. 7-12.
Marshalko O.V., Karpovich A.I. Therapy in 3 parts., Study guide / Minsk: RIPO, 2016 - Part 1: Pulmonology. - 2016 .-- 202 p.
Smolnikova M.V., Smirnova S.V., Ilyenkova N.A., Konopleva O.S. Immunological markers of uncontrolled course of bronchial asthma in children // Medical Immunology. - 2017. Vol.19, No. 4. S. 453-460.
Starostina L.S. Acute respiratory viral infection in children with bronchial asthma // Otorhinolorhinogology and Pulmonology. - 2017.- No. 3. 59-64.
Chernussky V.G., Odinets Yu.V., Morozova A.D. The influence of the alpha-blocker pyrroxan on the parameters of bronchial patency in children with bronchial asthma // Medicine of the Year and Tomorrow. - 2010. - No. 1. -S. 118-120.
Chernysheva OE, MODERN PREDICTIONS ON THE PATHOGENESIS OF AD IN CHILDREN "Child's Health", 2014 - ISSN 2224-0551 ¹ 5 (56) • 2014.
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.